Skip to Main Content

Paper Details

Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Oncotarget
65
2015
/FLI1 target genes, CDK4, CDK4/6, ETS transcription factor, EWS, EWS gene, Ewing sarcoma, Ewing sarcoma cell lines, Ewing sarcoma cells, FLI1, bone and soft tissue tumor, children, cyclin D1, human, human Ewing sarcoma cell lines, patients, sarcoma, super-enhancer, super-enhancers
Author NameAffiliation
Brian D CromptonDana-Farber Cancer Institute and Boston Children's Hospital
Glenn S CowleyBroad Institute
Francisca VazquezBroad Institute
Barbara A WeirBroad Institute
Barbara A WeirBroad Institute
Aviad TsherniakBroad Institute
Aviad TsherniakBroad Institute
Sunkyu KimNovartis Institute for Biomedical Research
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital
Gabriela AlexeBoston University
Gabriela AlexeBroad Institute
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital
Gabriela AlexeBroad Institute
Gabriela AlexeBoston University
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital
Kimberly StegmaierBroad Institute
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital
Kimberly StegmaierBroad Institute
  • 1 - 18

Datasets

Release 1.2